{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/IMDX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Insight Molecular Diagnostics Inc., listed on NASDAQ under ticker IMDX, with ISIN US68235C2061 and LEI 549300BIYAW8GO410287. Its security type is Corporate, its segment is not on the record, its sector is 2835 In Vitro & In Vivo Diagnostic Substances, and its jurisdiction is United States — California. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 35 filings in the window 2025-11-08 to 2026-11-08, across 17 filing days. The median gap between filing days is 15.5 days, against a NASDAQ median of 6.0 days and a sector median of 6.5 days. The median filing count is 52 for NASDAQ and 61 for the sector. The median latency is 5.0 days for NASDAQ and 4 days for the sector. The latest filing is dated 2026-09-21 and is a corporate_news filing, 48 days before the record date.\n\n## Auditor\n\nThe auditor of record is CBIZ CPAs P.C., located in Costa Mesa, CA. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. Domicile change is not on the record. Segment move is not on the record. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe record holds five research houses named on the issuer's investor-relations page: Stephens Inc, Lake Street, BTIG, Needham and Lucid Capital Markets.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://data.sec.gov/submissions/CIK0001642380.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/IMDX (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1642380/000164238026000004/imdx-20251231.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://investors.imdxinc.com/analyst_coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/IMDX (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1642380/000164238026000004/imdx-20251231.htm",
    "state": "sourced",
    "value": "CBIZ CPAs P.C."
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1642380/000164238026000004/imdx-20251231.htm",
    "state": "sourced",
    "value": "199"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1642380/000164238026000004/imdx-20251231.htm",
    "state": "sourced",
    "value": "Costa Mesa, CA"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/IMDX",
  "coverage": {
   "count": 5,
   "houses": [
    {
     "analyst": "Mason Carrico",
     "house": "Stephens Inc",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investors.imdxinc.com/analyst_coverage",
     "state": "sourced"
    },
    {
     "analyst": "Thomas Flaten",
     "house": "Lake Street",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investors.imdxinc.com/analyst_coverage",
     "state": "sourced"
    },
    {
     "analyst": "Mark Massaro",
     "house": "BTIG",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investors.imdxinc.com/analyst_coverage",
     "state": "sourced"
    },
    {
     "analyst": "Mike Matson",
     "house": "Needham",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investors.imdxinc.com/analyst_coverage",
     "state": "sourced"
    },
    {
     "analyst": "Alex Nowak",
     "house": "Lucid Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://investors.imdxinc.com/analyst_coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://investors.imdxinc.com/analyst_coverage",
     "result": "read: 5 of 10 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 19,
     "median_cadence_gap_days": 6.5,
     "median_filings": 61,
     "median_latency_days": 4,
     "name": "2835 In Vitro & In Vivo Diagnostic Substances"
    }
   },
   "by_type": {
    "agm_egm": 2,
    "corporate_news": 6,
    "director_change": 1,
    "directors_dealings": 13,
    "prospectus": 1,
    "regulatory_filing": 4,
    "results": 8
   },
   "cadence_median_gap_days": 15.5,
   "filing_days": 17,
   "filings": 35,
   "latency_days": 48,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-09-21",
     "source": "https://www.sec.gov/Archives/edgar/data/1642380/000149315226043560/form8-k.htm",
     "title": "8-K — 8-K (items 1.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "10-Q",
     "date": "2026-08-10",
     "source": "https://www.sec.gov/Archives/edgar/data/1642380/000164238026000011/imdx-20260630.htm",
     "title": "10-Q — 10-Q",
     "type": "results"
    },
    {
     "category": "8-K",
     "date": "2026-08-10",
     "source": "https://www.sec.gov/Archives/edgar/data/1642380/000149315226036863/form8-k.htm",
     "title": "8-K — 8-K (items 2.02,7.01,8.01,9.01)",
     "type": "results"
    },
    {
     "category": "S-8",
     "date": "2026-07-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1642380/000149315226034564/forms-8.htm",
     "title": "S-8 — S-8",
     "type": "regulatory_filing"
    },
    {
     "category": "4",
     "date": "2026-07-06",
     "source": "https://www.sec.gov/Archives/edgar/data/1642380/000149315226032235/xslF345X06/ownership.xml",
     "title": "4 — 4",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-09-21",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/IMDX",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (ISINs mapped to the LEI)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest",
    "state": "sourced",
    "value": "US68235C2061"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001642380.json",
    "state": "sourced",
    "value": "United States — California"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US68235C2061)",
    "state": "sourced",
    "value": "549300BIYAW8GO410287"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001642380.json",
    "state": "sourced",
    "value": "Insight Molecular Diagnostics Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001642380.json",
    "state": "sourced",
    "value": "2835 In Vitro & In Vivo Diagnostic Substances"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001642380.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "IMDX"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:865bfd5c9fa4817f8a69747f9d6f4b510ea598713dcbf8f2813f69ee17739882",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/IMDX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:865bfd5c9fa4817f8a69747f9d6f4b510ea598713dcbf8f2813f69ee17739882",
 "path": "/us/NASDAQ/IMDX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Insight Molecular Diagnostics Inc., listed on NASDAQ under ticker IMDX, with ISIN US68235C2061 and LEI 549300BIYAW8GO410287. Its security type is Corporate, its segment is not on the record, its sector is 2835 In Vitro & In Vivo Diagnostic Substances, and its jurisdiction is United States — California. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 35 filings in the window 2025-11-08 to 2026-11-08, across 17 filing days. The median gap between filing days is 15.5 days, against a NASDAQ median of 6.0 days and a sector median of 6.5 days. The median filing count is 52 for NASDAQ and 61 for the sector. The median latency is 5.0 days for NASDAQ and 4 days for the sector. The latest filing is dated 2026-09-21 and is a corporate_news filing, 48 days before the record date.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is CBIZ CPAs P.C., located in Costa Mesa, CA. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. Domicile change is not on the record. Segment move is not on the record. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record holds five research houses named on the issuer's investor-relations page: Stephens Inc, Lake Street, BTIG, Needham and Lucid Capital Markets.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001642380.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/IMDX"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1642380/000164238026000004/imdx-20251231.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://investors.imdxinc.com/analyst_coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/IMDX"
  }
 ],
 "title": "Insight Molecular Diagnostics Inc. (IMDX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}